Kobayashi Pharmaceutical controversies

Red yeast rice product safety crisis

Kobayashi Pharmaceutical recalled products containing red yeast rice after receiving reports of kidney-related illnesses and other health problems. Investigations examined the presence of unintended compounds, manufacturing conditions, the company’s response to early complaints, and communication with authorities and the public. The incident led to expanding recalls, apologies, leadership changes, and demands for stronger quality-control and governance systems.